Literature DB >> 29959328

Misestimation of heritability and prediction accuracy of male-pattern baldness.

Chloe X Yap1, Julia Sidorenko1,2, Riccardo E Marioni3,4, Loic Yengo1, Naomi R Wray1,5, Peter M Visscher6,7.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29959328      PMCID: PMC6026149          DOI: 10.1038/s41467-018-04807-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


× No keyword cloud information.
Pirastu et al.[1] perform the largest GWAS to date on male-pattern baldness (MPB), discover 71 loci (of which 30 are new) and draw inference about its heritability and genetic architecture. They report a SNP heritability on the scale of liability (h2) of 94%, with 38% of total heritability explained by the 71 loci. From these estimates, they draw strong conclusions about the genetic architecture of MPB. However, the chosen definition of the phenotype and the applied transformation to the unobserved scale of liability have led to a large upwards bias of the estimates of these parameters, as shown here in theory and from data. In the UK Biobank (UKB), MPB is measured on a four-point ordinal scale (values 1–4, with 1 representing no sign of baldness). Using the same UKB sub-sample selection as Pirastu et al. (unrelated British, genetically Caucasian, n = 54,813), the proportion of men with self-report MPB in each category is 0.317, 0.229, 0.269 and 0.185, respectively. In analysis, the authors ignore 23% of the population with a score of 2, and define ‘cases’ as those with self-reported scores of 3 or 4, and ‘controls’ as self-reported scores of 1, leading to a ‘prevalence’ of 59%. Yet the reported h2 estimates are presented as if parameters in the (whole) population. An implicit assumption of their approach is that those self-reporting a score of 2, which they consider to be ‘rather dubious baldness’, are randomly drawn from the population. To determine if this assumption is valid, we took the 47 most associated independent autosomal loci that were identified independently[2-6,10] of the UKB data (to avoid bias) and then used the same UKB data as in Pirastu et al. to estimate the frequencies of the trait-increasing alleles for each of the 4 scores. The results (Fig. 1) show that these frequencies are approximately linear in scores 1–4, and clearly score 2 is not random with respect to liability. Moreover, the observed pattern is consistent with an additive model on the scale of these scores. Therefore, since a score of 2 is correlated with liability to MPB, ignoring individuals with a score of 2, without accounting for the resulting extreme tail ascertainment, will lead to a bias in the estimate of genetic parameters. We derived from theory the general transformation equation that should be applied to the estimate of heritability made on the binary observed scale in samples that are ascertained based on tail selection and/or oversampling of cases or controls () to achieve unbiased estimates of h2 (equation [1] in Supplementary Methods).
Fig. 1

Trait-increasing allele frequency by MPB score in UKB for 47 genome-wide significant GWAS loci identified in refs. [2–6,10]. For each of the 47 loci, the trait-increasing allele frequency in the UK Biobank sample is given on the y-axis, as a deviation from its frequency for men with a MPB score of 1. The x-axis labels represent the observed MPB categories in the UK Biobank

Trait-increasing allele frequency by MPB score in UKB for 47 genome-wide significant GWAS loci identified in refs. [2-6,10]. For each of the 47 loci, the trait-increasing allele frequency in the UK Biobank sample is given on the y-axis, as a deviation from its frequency for men with a MPB score of 1. The x-axis labels represent the observed MPB categories in the UK Biobank We first replicated the results of Pirastu et al., using their sampling design and model (as best as we could deduce from the details provided) and using the same UK Biobank data. The estimate for scores 3 + 4 vs. score 1 using GCTA[7] was 0.61 (s.e. = 0.03). If this is transformed to the scale of liability using the standard equation[8] (equation [2] in Supplementary Methods) then the estimate of h2 is 0.98 (standard error, s.e. = 0.04) similar to the estimate reported by Pirastu et al. However, the correct transformation (equation [1] in Supplementary Methods) generates an estimate of 0.64 (s.e. = 0.03). To empirically explore assumptions of the liability threshold model, we analysed random samples of 20,000 males dichotomised in a number of ways (Table 1). These analyses generated estimates of h2 in the range of 0.61–0.75. We also analysed MPB on the continuous scale of 1–4, which does not remove information through dichotomisation, transforming the estimate of heritability to the liability scale h2 = 0.69 (s.e. = 0.03)[9] (equation [3] in Supplementary Methods).
Table 1

Estimates of heritability of liability of MPB using different random samples of 20,000 men ascertained in different ways

MPB scores for casesMPB scores for controls \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$K_{\mathrm{L}}$$\end{document}KL \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$K_{\mathrm{U}}$$\end{document}KU P \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$h_{o[s]}^2({\mathrm{s}}.{\mathrm{e}}.)$$\end{document}ho[s]2(s.e.) \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$h_l^2({\mathrm{s}}.{\mathrm{e}}.)$$\end{document}hl2(s.e.) R 2a
41,2,30.810.190.190.36 (0.03)0.75 (0.06)0.15
3,41,20.540.460.460.46 (0.03)0.72 (0.05)0.16
2,3,410.680.320.320.41 (0.03)0.70 (0.05)0.17
3,4b10.320.460.590.61 (0.03)0.64 (0.03)0.16
410.320.190.370.96 (0.03)0.63 (0.02)0.13
Quantitative 1,2,3,40.59 (0.03)0.69 (0.03)0.16

KL proportion of the population in the lower tail, extreme controls. KU proportion of the population in the upper tail, cases. P proportion of the samples used for analyses that are cases.

aProportion of variance in liability explained by the 107-SNP predictor

bThe sampling strategy conducted by Pirastu et al.

Estimates of heritability of liability of MPB using different random samples of 20,000 men ascertained in different ways KL proportion of the population in the lower tail, extreme controls. KU proportion of the population in the upper tail, cases. P proportion of the samples used for analyses that are cases. aProportion of variance in liability explained by the 107-SNP predictor bThe sampling strategy conducted by Pirastu et al. We estimated the variance explained by the 107 SNP predictor from the difference in the estimate of total phenotypic variance in models excluding and including the predictor as a fixed effect. This method for estimation of the contribution of the SNP predictor to trait variation differs to that presented by Pirastu et al. In contrast to their approach, it does not depend on unbiased estimation of genetic variance in the two models. Moreover, it is accurate (the s.e. of estimating a phenotypic variance is small) and quantifies a parameter that is most relevant to epidemiology and risk prediction. From the estimate of the variance explained by the predictor, we calculated the proportion of variance it explained on the observed scale and then transformed this proportion to the scale of liability. Results (Table 1) imply that the variance in liability attributable to this predictor is ~15–20%, substantially less than claimed by the authors. In conclusion, the evidence presented by Pirastu et al. is not consistent with the claims that virtually all variation in liability to MPB is genetic and that common SNPs capture all that variation. A correct transformation from the observed scale to a scale of liability results in an estimate of SNP heritability of ~60–70%, and the 71-loci (107-SNP predictor) explains about 15–20% of variation in liability.
  10 in total

1.  GCTA: a tool for genome-wide complex trait analysis.

Authors:  Jian Yang; S Hong Lee; Michael E Goddard; Peter M Visscher
Journal:  Am J Hum Genet       Date:  2010-12-17       Impact factor: 11.025

2.  Heritability of polychotomous characters.

Authors:  D Gianola
Journal:  Genetics       Date:  1979-12       Impact factor: 4.562

3.  Estimating missing heritability for disease from genome-wide association studies.

Authors:  Sang Hong Lee; Naomi R Wray; Michael E Goddard; Peter M Visscher
Journal:  Am J Hum Genet       Date:  2011-03-03       Impact factor: 11.025

4.  Androgenetic alopecia: identification of four genetic risk loci and evidence for the contribution of WNT signaling to its etiology.

Authors:  Stefanie Heilmann; Amy K Kiefer; Nadine Fricker; Dmitriy Drichel; Axel M Hillmer; Christine Herold; Joyce Y Tung; Nicholas Eriksson; Silke Redler; Regina C Betz; Rui Li; Ari Kárason; Dale R Nyholt; Kijoung Song; Sita H Vermeulen; Stavroula Kanoni; George Dedoussis; Nicholas G Martin; Lambertus A Kiemeney; Vincent Mooser; Kari Stefansson; J Brent Richards; Tim Becker; Felix F Brockschmidt; David A Hinds; Markus M Nöthen
Journal:  J Invest Dermatol       Date:  2013-01-28       Impact factor: 8.551

5.  Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness.

Authors:  F F Brockschmidt; S Heilmann; J A Ellis; S Eigelshoven; S Hanneken; C Herold; S Moebus; M A Alblas; B Lippke; N Kluck; L Priebe; F A Degenhardt; R A Jamra; C Meesters; K-H Jöckel; R Erbel; S Harrap; J Schumacher; H Fröhlich; R Kruse; A M Hillmer; T Becker; M M Nöthen
Journal:  Br J Dermatol       Date:  2011-12       Impact factor: 9.302

6.  Male-pattern baldness susceptibility locus at 20p11.

Authors:  J Brent Richards; Xin Yuan; Frank Geller; Dawn Waterworth; Veronique Bataille; Daniel Glass; Kijoung Song; Gerard Waeber; Peter Vollenweider; Katja K H Aben; Lambertus A Kiemeney; Bragi Walters; Nicole Soranzo; Unnur Thorsteinsdottir; Augustine Kong; Thorunn Rafnar; Panos Deloukas; Patrick Sulem; Hreinn Stefansson; Kari Stefansson; Tim D Spector; Vincent Mooser
Journal:  Nat Genet       Date:  2008-10-12       Impact factor: 38.330

7.  Susceptibility variants for male-pattern baldness on chromosome 20p11.

Authors:  Axel M Hillmer; Felix F Brockschmidt; Sandra Hanneken; Sibylle Eigelshoven; Michael Steffens; Antonia Flaquer; Stefan Herms; Tim Becker; Anne-Katrin Kortüm; Dale R Nyholt; Zhen Zhen Zhao; Grant W Montgomery; Nicholas G Martin; Thomas W Mühleisen; Margrieta A Alblas; Susanne Moebus; Karl-Heinz Jöckel; Martina Bröcker-Preuss; Raimund Erbel; Roman Reinartz; Regina C Betz; Sven Cichon; Peter Propping; Max P Baur; Thomas F Wienker; Roland Kruse; Markus M Nöthen
Journal:  Nat Genet       Date:  2008-10-12       Impact factor: 38.330

8.  Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.

Authors:  Rui Li; Felix F Brockschmidt; Amy K Kiefer; Hreinn Stefansson; Dale R Nyholt; Kijoung Song; Sita H Vermeulen; Stavroula Kanoni; Daniel Glass; Sarah E Medland; Maria Dimitriou; Dawn Waterworth; Joyce Y Tung; Frank Geller; Stefanie Heilmann; Axel M Hillmer; Veronique Bataille; Sibylle Eigelshoven; Sandra Hanneken; Susanne Moebus; Christine Herold; Martin den Heijer; Grant W Montgomery; Panos Deloukas; Nicholas Eriksson; Andrew C Heath; Tim Becker; Patrick Sulem; Massimo Mangino; Peter Vollenweider; Tim D Spector; George Dedoussis; Nicholas G Martin; Lambertus A Kiemeney; Vincent Mooser; Kari Stefansson; David A Hinds; Markus M Nöthen; J Brent Richards
Journal:  PLoS Genet       Date:  2012-05-31       Impact factor: 5.917

9.  GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.

Authors:  Nicola Pirastu; Peter K Joshi; Paul S de Vries; Marilyn C Cornelis; Paul M McKeigue; NaNa Keum; Nora Franceschini; Marco Colombo; Edward L Giovannucci; Athina Spiliopoulou; Lude Franke; Kari E North; Peter Kraft; Alanna C Morrison; Tõnu Esko; James F Wilson
Journal:  Nat Commun       Date:  2017-11-17       Impact factor: 14.919

10.  Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness.

Authors:  Stefanie Heilmann-Heimbach; Christine Herold; Lara M Hochfeld; Axel M Hillmer; Dale R Nyholt; Julian Hecker; Asif Javed; Elaine G Y Chew; Sonali Pechlivanis; Dmitriy Drichel; Xiu Ting Heng; Ricardo C-H Del Rosario; Heide L Fier; Ralf Paus; Rico Rueedi; Tessel E Galesloot; Susanne Moebus; Thomas Anhalt; Shyam Prabhakar; Rui Li; Stavroula Kanoni; George Papanikolaou; Zoltán Kutalik; Panos Deloukas; Michael P Philpott; Gérard Waeber; Tim D Spector; Peter Vollenweider; Lambertus A L M Kiemeney; George Dedoussis; J Brent Richards; Michael Nothnagel; Nicholas G Martin; Tim Becker; David A Hinds; Markus M Nöthen
Journal:  Nat Commun       Date:  2017-03-08       Impact factor: 14.919

  10 in total
  7 in total

1.  Genetic heterogeneity and subtypes of major depression.

Authors:  Thuy-Dung Nguyen; Arvid Harder; Ying Xiong; Kaarina Kowalec; Sara Hägg; Na Cai; Ralf Kuja-Halkola; Christina Dalman; Patrick F Sullivan; Yi Lu
Journal:  Mol Psychiatry       Date:  2022-01-08       Impact factor: 13.437

2.  A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment.

Authors:  Andrew J Schork; Hyejung Won; Vivek Appadurai; Ron Nudel; Mike Gandal; Olivier Delaneau; Malene Revsbech Christiansen; David M Hougaard; Marie Bækved-Hansen; Jonas Bybjerg-Grauholm; Marianne Giørtz Pedersen; Esben Agerbo; Carsten Bøcker Pedersen; Benjamin M Neale; Mark J Daly; Naomi R Wray; Merete Nordentoft; Ole Mors; Anders D Børglum; Preben Bo Mortensen; Alfonso Buil; Wesley K Thompson; Daniel H Geschwind; Thomas Werge
Journal:  Nat Neurosci       Date:  2019-01-28       Impact factor: 24.884

3.  Insights into the genetic basis of retinal detachment.

Authors:  Thibaud S Boutin; David G Charteris; Aman Chandra; Susan Campbell; Caroline Hayward; Archie Campbell; Priyanka Nandakumar; David Hinds; Danny Mitry; Veronique Vitart
Journal:  Hum Mol Genet       Date:  2020-03-13       Impact factor: 6.150

4.  Author Correction: GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk.

Authors:  Nicola Pirastu; Peter K Joshi; Paul S de Vries; Marilyn C Cornelis; Paul M McKeigue; NaNa Keum; Nora Franceschini; Marco Colombo; Edward L Giovannucci; Athina Spiliopoulou; Lude Franke; Kari E North; Peter Kraft; Alanna C Morrison; Tõnu Esko; James F Wilson
Journal:  Nat Commun       Date:  2018-06-29       Impact factor: 14.919

5.  Reply to 'Misestimation of heritability and prediction accuracy of male-pattern baldness'.

Authors:  Nicola Pirastu; Peter K Joshi; Paul S de Vries; Marilyn C Cornelis; NaNa Keum; Nora Franceschini; Marco Colombo; Edward L Giovannucci; Athina Spiliopoulou; Lude Franke; Kari E North; Peter Kraft; Alanna C Morrison; Tõnu Esko; James F Wilson
Journal:  Nat Commun       Date:  2018-06-29       Impact factor: 14.919

6.  Dissection of genetic variation and evidence for pleiotropy in male pattern baldness.

Authors:  Chloe X Yap; Julia Sidorenko; Yang Wu; Kathryn E Kemper; Jian Yang; Naomi R Wray; Matthew R Robinson; Peter M Visscher
Journal:  Nat Commun       Date:  2018-12-20       Impact factor: 14.919

7.  A large population-based investigation into the genetics of susceptibility to gastrointestinal infections and the link between gastrointestinal infections and mental illness.

Authors:  Ron Nudel; Vivek Appadurai; Andrew J Schork; Alfonso Buil; Jonas Bybjerg-Grauholm; Anders D Børglum; Mark J Daly; Ole Mors; David M Hougaard; Preben Bo Mortensen; Thomas Werge; Merete Nordentoft; Wesley K Thompson; Michael E Benros
Journal:  Hum Genet       Date:  2020-03-09       Impact factor: 4.132

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.